Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.27 USD | +0.63% | +3.28% | +4.60% |
Evolution of the average Target Price on Supernus Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Supernus Pharmaceuticals, Inc.
Piper Sandler | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- SUPN Stock
- Consensus Supernus Pharmaceuticals, Inc.